Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing

Autores
Taha, Muhamed-Kheir; Hedberg, Sara Thulin; Szatanik, Marek; Hong, Eva; Ruckly, Corinne; Abad, Raquel; Bertrand, Sophie; Carion, Francoise; Claus, Heike; Corso, Alejandra; Enríquez, Rocío; Heuberger, Sigrid; Hryniewicz, Waleria; Jolley, Keith A.; Kriz, Paula; Mollerach, Marta; Musilek, Martin; Neri, Arianna; Olcén, Per; Pana, Marina; Skoczynska, Anna; Sorhouet Pereira, Cecilia; Stefanelli, Paola; Tzanakaki, Georgina; Unemo, Magnus; Vázquez, Julio A.; Vogel, Ulrich; Wasko, Izabela
Año de publicación
2010
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Fil: Taha, Muhamed-Kheir. National Reference Centre for Meningococci. Institut Pasteur; Francia.
Fil: Hedberg, Sara Thulin. Örebro University Hospital. National Reference Laboratory for Pathogenic Neisseria; Suiza.
Fil: Szatanik, Marek. National Reference Centre for Meningococci. Institut Pasteur; Francia.
Fil: Hong, Eva. National Reference Centre for Meningococci. Institut Pasteur; Francia.
Fil: Ruckly, Corinne. National Reference Centre for Meningococci. Institut Pasteur; Francia.
Fil: Abad, Raquel. Institute of Health Carlos III. Reference Laboratory for Neisserias; España.
Fil: Bertrand, Sophie. Scientific Institute of Public Health. National Reference Centre for Neisseria meningitidis; Belgica.
Fil: Carion, Francoise. Scientific Institute of Public Health. National Reference Centre for Neisseria meningitidis; Belgica.
Fil: Claus, Heike. University of Würzburg. Institute for Hygiene and Microbiology; Alemania.
Fil: Corso, Alejandra. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacterilogía; Argentina.
Fil: Enríquez, Rocío. Institute of Health Carlos III. Reference Laboratory for Neisserias; España.
Fil: Heuberger, Sigrid. Austrian Agency for Health and Food Safety. National Reference Centre for Meningococci; Australia.
Fil: Hryniewicz, Waleria. National Medicines Institute. National Reference Centre for Bacterial Meningitis; Polonia.
Fil: Jolley, Keith A. University of Oxford. Department of Zoology; Reino Unido.
Fil: Kriz, Paula. The National Institute of Public Health (NIPH). National Reference Laboratory for Meningococcal Infections; República Checa.
Fil: Mollerach, Marta. Universidad de Buenos Aires. Cátedra de Microbiología Facultad de Farmacia y Bioquimíca; Argentina.
Fil: Musilek, Martin. The National Institute of Public Health (NIPH). National Reference Laboratory for Meningococcal Infections; República Checa.
Fil: Neri, Arianna. Instituto Superiore di Sanitá. Department of Infectious Parasitic and Immune-Mediated Diseases; Italia.
Fil: Olcén, Per. Örebro University Hospital. National Reference Laboratory for Pathogenic Neisseria; Suiza.
Fil: Pana, Marina. National Reference Center for Neisseria meningitidis. Cantacuzino Institute; Rumania.
Fil: Skoczynska, Anna. National Medicines Institute. National Reference Centre for Bacterial Meningitis; Polonia.
Fil: Sorhouet Pereira, Cecilia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacterilogía; Argentina.
Fil: Stefanelli, Paola. Instituto Superiore di Sanitá. Department of Infectious Parasitic and Immune-Mediated Diseases; Italia.
Fil: Tzanakaki, Georgina. National School of Public Health. National Meningitis Reference Laboratory; Grecia.
Fil: Unemo, Magnus. Örebro University Hospital. National Reference Laboratory for Pathogenic Neisseria; Suiza.
Fil: Vázquez, Julio A. Institute of Health Carlos III. Reference Laboratory for Neisserias; España.
Fil: Vogel, Ulrich. University of Würzburg. Institute for Hygiene and Microbiology; Alemania.
Fil: Wasko, Izabela. National Medicines Institute. National Reference Centre for Bacterial Meningitis; Polonia.
Identification of clinical isolates of Neisseria meningitidis that are resistant to rifampin is important to avoid prophylaxis failure in contacts of patients, but it is hindered by the absence of a breakpoint for resistance, despite many efforts toward standardization. We examined a large number (n 392) of clinical meningococcal isolates, spanning 25 years (1984 to 2009), that were collected in 11 European countries, Argentina, and the Central African Republic. The collection comprises all clinical isolates with MICs of >0.25 mg/liter (n 161) received by the national reference laboratories for meningococci in the participating countries. Representative isolates displaying rifampin MICs of <0.25 mg/liter were also examined (n 231). Typing of isolates was performed, and a 660-bp DNA fragment of the rpoB gene was sequenced. Sequences differing by at least one nucleotide were defined as unique rpoB alleles. The geometric mean of the MICs was calculated for isolates displaying the same allele. The clinical isolates displaying rifampin MICs of >1 mg/liter possessed rpoB alleles with nonsynonymous mutations at four critical amino acid residues, D542, H552, S548, and S557, that were absent in the alleles found in all isolates with MICs of <1 mg/liter. Rifampin-susceptible isolates could be defined as those with MICs of <1 mg/liter. The rpoB allele sequence and isolate data have been incorporated into the PubMLST Neisseria database (http://pubmlst.org/neisseria/). The rifampin-resistant isolates belonged to diverse genetic lineages and were associated with lower levels of bacteremia and inflammatory cytokines in mice. This biological cost may explain the lack of clonal expansion of these isolates.
Fuente
Antimicrobial Agents and Chemotherapy 2010;54(9):3651–3658
Materia
Secuencia de Aminoácidos
Antibacterianos
Proteínas Bacterianas
Farmacorresistencia Bacteriana
Ratones
Ratones Consanguíneos BALB C
Ratones Transgénicos
Neisseria meningitidis
Filogenia
Rifampin
Nivel de accesibilidad
acceso abierto
Condiciones de uso
Repositorio
Sistema de Gestión del Conocimiento ANLIS MALBRÁN
Institución
Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
OAI Identificador
oai:sgc.anlis.gob.ar:123456789/215

id SGCANLIS_e2e5a681b5f5430b63fa6bb690f32111
oai_identifier_str oai:sgc.anlis.gob.ar:123456789/215
network_acronym_str SGCANLIS
repository_id_str a
network_name_str Sistema de Gestión del Conocimiento ANLIS MALBRÁN
spelling Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencingTaha, Muhamed-KheirHedberg, Sara ThulinSzatanik, MarekHong, EvaRuckly, CorinneAbad, RaquelBertrand, SophieCarion, FrancoiseClaus, HeikeCorso, AlejandraEnríquez, RocíoHeuberger, SigridHryniewicz, WaleriaJolley, Keith A.Kriz, PaulaMollerach, MartaMusilek, MartinNeri, AriannaOlcén, PerPana, MarinaSkoczynska, AnnaSorhouet Pereira, CeciliaStefanelli, PaolaTzanakaki, GeorginaUnemo, MagnusVázquez, Julio A.Vogel, UlrichWasko, IzabelaSecuencia de AminoácidosAntibacterianosProteínas BacterianasFarmacorresistencia BacterianaRatonesRatones Consanguíneos BALB CRatones TransgénicosNeisseria meningitidisFilogeniaRifampinFil: Taha, Muhamed-Kheir. National Reference Centre for Meningococci. Institut Pasteur; Francia.Fil: Hedberg, Sara Thulin. Örebro University Hospital. National Reference Laboratory for Pathogenic Neisseria; Suiza.Fil: Szatanik, Marek. National Reference Centre for Meningococci. Institut Pasteur; Francia.Fil: Hong, Eva. National Reference Centre for Meningococci. Institut Pasteur; Francia.Fil: Ruckly, Corinne. National Reference Centre for Meningococci. Institut Pasteur; Francia.Fil: Abad, Raquel. Institute of Health Carlos III. Reference Laboratory for Neisserias; España.Fil: Bertrand, Sophie. Scientific Institute of Public Health. National Reference Centre for Neisseria meningitidis; Belgica.Fil: Carion, Francoise. Scientific Institute of Public Health. National Reference Centre for Neisseria meningitidis; Belgica.Fil: Claus, Heike. University of Würzburg. Institute for Hygiene and Microbiology; Alemania.Fil: Corso, Alejandra. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacterilogía; Argentina.Fil: Enríquez, Rocío. Institute of Health Carlos III. Reference Laboratory for Neisserias; España.Fil: Heuberger, Sigrid. Austrian Agency for Health and Food Safety. National Reference Centre for Meningococci; Australia.Fil: Hryniewicz, Waleria. National Medicines Institute. National Reference Centre for Bacterial Meningitis; Polonia.Fil: Jolley, Keith A. University of Oxford. Department of Zoology; Reino Unido.Fil: Kriz, Paula. The National Institute of Public Health (NIPH). National Reference Laboratory for Meningococcal Infections; República Checa.Fil: Mollerach, Marta. Universidad de Buenos Aires. Cátedra de Microbiología Facultad de Farmacia y Bioquimíca; Argentina.Fil: Musilek, Martin. The National Institute of Public Health (NIPH). National Reference Laboratory for Meningococcal Infections; República Checa.Fil: Neri, Arianna. Instituto Superiore di Sanitá. Department of Infectious Parasitic and Immune-Mediated Diseases; Italia.Fil: Olcén, Per. Örebro University Hospital. National Reference Laboratory for Pathogenic Neisseria; Suiza.Fil: Pana, Marina. National Reference Center for Neisseria meningitidis. Cantacuzino Institute; Rumania.Fil: Skoczynska, Anna. National Medicines Institute. National Reference Centre for Bacterial Meningitis; Polonia.Fil: Sorhouet Pereira, Cecilia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacterilogía; Argentina.Fil: Stefanelli, Paola. Instituto Superiore di Sanitá. Department of Infectious Parasitic and Immune-Mediated Diseases; Italia.Fil: Tzanakaki, Georgina. National School of Public Health. National Meningitis Reference Laboratory; Grecia.Fil: Unemo, Magnus. Örebro University Hospital. National Reference Laboratory for Pathogenic Neisseria; Suiza.Fil: Vázquez, Julio A. Institute of Health Carlos III. Reference Laboratory for Neisserias; España.Fil: Vogel, Ulrich. University of Würzburg. Institute for Hygiene and Microbiology; Alemania.Fil: Wasko, Izabela. National Medicines Institute. National Reference Centre for Bacterial Meningitis; Polonia.Identification of clinical isolates of Neisseria meningitidis that are resistant to rifampin is important to avoid prophylaxis failure in contacts of patients, but it is hindered by the absence of a breakpoint for resistance, despite many efforts toward standardization. We examined a large number (n 392) of clinical meningococcal isolates, spanning 25 years (1984 to 2009), that were collected in 11 European countries, Argentina, and the Central African Republic. The collection comprises all clinical isolates with MICs of >0.25 mg/liter (n 161) received by the national reference laboratories for meningococci in the participating countries. Representative isolates displaying rifampin MICs of <0.25 mg/liter were also examined (n 231). Typing of isolates was performed, and a 660-bp DNA fragment of the rpoB gene was sequenced. Sequences differing by at least one nucleotide were defined as unique rpoB alleles. The geometric mean of the MICs was calculated for isolates displaying the same allele. The clinical isolates displaying rifampin MICs of >1 mg/liter possessed rpoB alleles with nonsynonymous mutations at four critical amino acid residues, D542, H552, S548, and S557, that were absent in the alleles found in all isolates with MICs of <1 mg/liter. Rifampin-susceptible isolates could be defined as those with MICs of <1 mg/liter. The rpoB allele sequence and isolate data have been incorporated into the PubMLST Neisseria database (http://pubmlst.org/neisseria/). The rifampin-resistant isolates belonged to diverse genetic lineages and were associated with lower levels of bacteremia and inflammatory cytokines in mice. This biological cost may explain the lack of clonal expansion of these isolates.2010-09info:ar-repo/semantics/articuloinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdf1098-6596http://sgc.anlis.gob.ar/handle/123456789/215http://aac.asm.org/content/54/9/3651.full.pdf+html10.1128/AAC.00315-10Antimicrobial Agents and Chemotherapy 2010;54(9):3651–3658reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁNinstname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"instacron:ANLISAntimicrobial agents and chemotherapyenginfo:eu-repo/semantics/openAccess2026-01-08T11:19:47Zoai:sgc.anlis.gob.ar:123456789/215Institucionalhttp://sgc.anlis.gob.ar/Organismo científico-tecnológicoNo correspondehttp://sgc.anlis.gob.ar/oai/biblioteca@anlis.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:a2026-01-08 11:19:47.77Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"false
dc.title.none.fl_str_mv Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing
title Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing
spellingShingle Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing
Taha, Muhamed-Kheir
Secuencia de Aminoácidos
Antibacterianos
Proteínas Bacterianas
Farmacorresistencia Bacteriana
Ratones
Ratones Consanguíneos BALB C
Ratones Transgénicos
Neisseria meningitidis
Filogenia
Rifampin
title_short Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing
title_full Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing
title_fullStr Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing
title_full_unstemmed Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing
title_sort Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing
dc.creator.none.fl_str_mv Taha, Muhamed-Kheir
Hedberg, Sara Thulin
Szatanik, Marek
Hong, Eva
Ruckly, Corinne
Abad, Raquel
Bertrand, Sophie
Carion, Francoise
Claus, Heike
Corso, Alejandra
Enríquez, Rocío
Heuberger, Sigrid
Hryniewicz, Waleria
Jolley, Keith A.
Kriz, Paula
Mollerach, Marta
Musilek, Martin
Neri, Arianna
Olcén, Per
Pana, Marina
Skoczynska, Anna
Sorhouet Pereira, Cecilia
Stefanelli, Paola
Tzanakaki, Georgina
Unemo, Magnus
Vázquez, Julio A.
Vogel, Ulrich
Wasko, Izabela
author Taha, Muhamed-Kheir
author_facet Taha, Muhamed-Kheir
Hedberg, Sara Thulin
Szatanik, Marek
Hong, Eva
Ruckly, Corinne
Abad, Raquel
Bertrand, Sophie
Carion, Francoise
Claus, Heike
Corso, Alejandra
Enríquez, Rocío
Heuberger, Sigrid
Hryniewicz, Waleria
Jolley, Keith A.
Kriz, Paula
Mollerach, Marta
Musilek, Martin
Neri, Arianna
Olcén, Per
Pana, Marina
Skoczynska, Anna
Sorhouet Pereira, Cecilia
Stefanelli, Paola
Tzanakaki, Georgina
Unemo, Magnus
Vázquez, Julio A.
Vogel, Ulrich
Wasko, Izabela
author_role author
author2 Hedberg, Sara Thulin
Szatanik, Marek
Hong, Eva
Ruckly, Corinne
Abad, Raquel
Bertrand, Sophie
Carion, Francoise
Claus, Heike
Corso, Alejandra
Enríquez, Rocío
Heuberger, Sigrid
Hryniewicz, Waleria
Jolley, Keith A.
Kriz, Paula
Mollerach, Marta
Musilek, Martin
Neri, Arianna
Olcén, Per
Pana, Marina
Skoczynska, Anna
Sorhouet Pereira, Cecilia
Stefanelli, Paola
Tzanakaki, Georgina
Unemo, Magnus
Vázquez, Julio A.
Vogel, Ulrich
Wasko, Izabela
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Secuencia de Aminoácidos
Antibacterianos
Proteínas Bacterianas
Farmacorresistencia Bacteriana
Ratones
Ratones Consanguíneos BALB C
Ratones Transgénicos
Neisseria meningitidis
Filogenia
Rifampin
topic Secuencia de Aminoácidos
Antibacterianos
Proteínas Bacterianas
Farmacorresistencia Bacteriana
Ratones
Ratones Consanguíneos BALB C
Ratones Transgénicos
Neisseria meningitidis
Filogenia
Rifampin
dc.description.none.fl_txt_mv Fil: Taha, Muhamed-Kheir. National Reference Centre for Meningococci. Institut Pasteur; Francia.
Fil: Hedberg, Sara Thulin. Örebro University Hospital. National Reference Laboratory for Pathogenic Neisseria; Suiza.
Fil: Szatanik, Marek. National Reference Centre for Meningococci. Institut Pasteur; Francia.
Fil: Hong, Eva. National Reference Centre for Meningococci. Institut Pasteur; Francia.
Fil: Ruckly, Corinne. National Reference Centre for Meningococci. Institut Pasteur; Francia.
Fil: Abad, Raquel. Institute of Health Carlos III. Reference Laboratory for Neisserias; España.
Fil: Bertrand, Sophie. Scientific Institute of Public Health. National Reference Centre for Neisseria meningitidis; Belgica.
Fil: Carion, Francoise. Scientific Institute of Public Health. National Reference Centre for Neisseria meningitidis; Belgica.
Fil: Claus, Heike. University of Würzburg. Institute for Hygiene and Microbiology; Alemania.
Fil: Corso, Alejandra. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacterilogía; Argentina.
Fil: Enríquez, Rocío. Institute of Health Carlos III. Reference Laboratory for Neisserias; España.
Fil: Heuberger, Sigrid. Austrian Agency for Health and Food Safety. National Reference Centre for Meningococci; Australia.
Fil: Hryniewicz, Waleria. National Medicines Institute. National Reference Centre for Bacterial Meningitis; Polonia.
Fil: Jolley, Keith A. University of Oxford. Department of Zoology; Reino Unido.
Fil: Kriz, Paula. The National Institute of Public Health (NIPH). National Reference Laboratory for Meningococcal Infections; República Checa.
Fil: Mollerach, Marta. Universidad de Buenos Aires. Cátedra de Microbiología Facultad de Farmacia y Bioquimíca; Argentina.
Fil: Musilek, Martin. The National Institute of Public Health (NIPH). National Reference Laboratory for Meningococcal Infections; República Checa.
Fil: Neri, Arianna. Instituto Superiore di Sanitá. Department of Infectious Parasitic and Immune-Mediated Diseases; Italia.
Fil: Olcén, Per. Örebro University Hospital. National Reference Laboratory for Pathogenic Neisseria; Suiza.
Fil: Pana, Marina. National Reference Center for Neisseria meningitidis. Cantacuzino Institute; Rumania.
Fil: Skoczynska, Anna. National Medicines Institute. National Reference Centre for Bacterial Meningitis; Polonia.
Fil: Sorhouet Pereira, Cecilia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacterilogía; Argentina.
Fil: Stefanelli, Paola. Instituto Superiore di Sanitá. Department of Infectious Parasitic and Immune-Mediated Diseases; Italia.
Fil: Tzanakaki, Georgina. National School of Public Health. National Meningitis Reference Laboratory; Grecia.
Fil: Unemo, Magnus. Örebro University Hospital. National Reference Laboratory for Pathogenic Neisseria; Suiza.
Fil: Vázquez, Julio A. Institute of Health Carlos III. Reference Laboratory for Neisserias; España.
Fil: Vogel, Ulrich. University of Würzburg. Institute for Hygiene and Microbiology; Alemania.
Fil: Wasko, Izabela. National Medicines Institute. National Reference Centre for Bacterial Meningitis; Polonia.
Identification of clinical isolates of Neisseria meningitidis that are resistant to rifampin is important to avoid prophylaxis failure in contacts of patients, but it is hindered by the absence of a breakpoint for resistance, despite many efforts toward standardization. We examined a large number (n 392) of clinical meningococcal isolates, spanning 25 years (1984 to 2009), that were collected in 11 European countries, Argentina, and the Central African Republic. The collection comprises all clinical isolates with MICs of >0.25 mg/liter (n 161) received by the national reference laboratories for meningococci in the participating countries. Representative isolates displaying rifampin MICs of <0.25 mg/liter were also examined (n 231). Typing of isolates was performed, and a 660-bp DNA fragment of the rpoB gene was sequenced. Sequences differing by at least one nucleotide were defined as unique rpoB alleles. The geometric mean of the MICs was calculated for isolates displaying the same allele. The clinical isolates displaying rifampin MICs of >1 mg/liter possessed rpoB alleles with nonsynonymous mutations at four critical amino acid residues, D542, H552, S548, and S557, that were absent in the alleles found in all isolates with MICs of <1 mg/liter. Rifampin-susceptible isolates could be defined as those with MICs of <1 mg/liter. The rpoB allele sequence and isolate data have been incorporated into the PubMLST Neisseria database (http://pubmlst.org/neisseria/). The rifampin-resistant isolates belonged to diverse genetic lineages and were associated with lower levels of bacteremia and inflammatory cytokines in mice. This biological cost may explain the lack of clonal expansion of these isolates.
description Fil: Taha, Muhamed-Kheir. National Reference Centre for Meningococci. Institut Pasteur; Francia.
publishDate 2010
dc.date.none.fl_str_mv 2010-09
dc.type.none.fl_str_mv info:ar-repo/semantics/articulo
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv 1098-6596
http://sgc.anlis.gob.ar/handle/123456789/215
http://aac.asm.org/content/54/9/3651.full.pdf+html
10.1128/AAC.00315-10
identifier_str_mv 1098-6596
10.1128/AAC.00315-10
url http://sgc.anlis.gob.ar/handle/123456789/215
http://aac.asm.org/content/54/9/3651.full.pdf+html
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Antimicrobial agents and chemotherapy
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv Antimicrobial Agents and Chemotherapy 2010;54(9):3651–3658
reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁN
instname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
instacron:ANLIS
reponame_str Sistema de Gestión del Conocimiento ANLIS MALBRÁN
collection Sistema de Gestión del Conocimiento ANLIS MALBRÁN
instname_str Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
instacron_str ANLIS
institution ANLIS
repository.name.fl_str_mv Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
repository.mail.fl_str_mv biblioteca@anlis.gov.ar
_version_ 1853761594922631168
score 13.113929